We are live on ! Find out more
GNBT

GENEREX BIOTECHNOLOGY CORP
GNBT

Delisted

GNBT was delisted on the 20th of October, 2010.

Back to rankings

1 hedge funds and large institutions have $598 invested in GENEREX BIOTECHNOLOGY CORP in 2014 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

42% less capital invested

Capital invested by funds: $1.02K → $598 (-$425)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Janney Montgomery Scott
1
Janney Montgomery Scott
Pennsylvania
$598 – – –

GNBT Hedge Fund Activity: Q4 2014 in Review

1 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in GENEREX BIOTECHNOLOGY CORP (GNBT) for Q4 2014, worth a combined $598 — down 42% from $1.02K a quarter earlier.

Fund positioning in GNBT was balanced in Q4 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held GENEREX BIOTECHNOLOGY CORP (GNBT) as of Q4 2014, unchanged from Q3 2014.
  • Funds reported $598 of GENEREX BIOTECHNOLOGY CORP stock for Q4 2014, down 42% quarter-over-quarter.
  • 0 funds opened new GENEREX BIOTECHNOLOGY CORP positions in Q4 2014 and 0 closed out.

Based on aggregated 13F filings for Q4 2014.